Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Esophageal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms 3 Head and Neck Neoplasms 3 Prostatic Neoplasms 2 Phyllodes Tumor 2 Carcinoma, Squamous Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Sarcoma 1 Postoperative Complications 1 Oropharyngeal Neoplasms 1 Neoplastic Cells, Circulating 1 Mouth Neoplasms 1 Lymphatic Metastasis 1 Liver Neoplasms 1 Laryngeal Neoplasms 1 Laryngeal Diseases 1 High-Risk Cancer 1 Endometrial Neoplasms 1 Carcinoma, Lobular 1 Carcinoma, Hepatocellular 1 Breast Cancer Radiotherapy 1

Interventions

Cisplatin 182 Radiotherapy 81 Paclitaxel 80 Brachytherapy 74 Carboplatin 72 pembrolizumab 63 Bevacizumab 40 Surveys and Questionnaires 29 Colposcopy 29 Radiation 28 Gemcitabine 28 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 27 Topotecan 26 Magnetic Resonance Spectroscopy 24 Blood Specimen Collection 23 human papillomavirus vaccine, L1 type 16, 18 22 Nivolumab 22 Drug Therapy 22 Papillomavirus Vaccines 20 atezolizumab 19 Platinum 19 Radiotherapy, Intensity-Modulated 18 Biopsy 18 Docetaxel 17 Taxes 16 Cyclophosphamide 16 Early Intervention, Educational 15 1,2-diaminocyclohexaneplatinum II citrate 15 Methods 14 fludarabine 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × Radiotherapy, Adjuvant × Clear all

NCT04989647 2023-09-07

CERVANTES

The Central and Eastern European Gynecologic Oncology Group

Phase 3 Recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡